Encellin Reveals Positive Interim Results In Type 1 Diabetes
06 Jan 2026 //
BUSINESSWIRE
Encellin Closes $9.9M Financing Led by Khosla Ventures
13 Dec 2023 //
BUSINESSWIRE
Encellin raises about $10M for type 1 diabetes cell replacement therapy
13 Dec 2023 //
ENDPTS

Market Place
Sourcing Support